Meet our board of advisors

At QbD Group, we believe that continuous growth and innovation require the right expertise and strategic insights. To strengthen our position in the life sciences industry, we have established a Board of Advisors, an esteemed group of industry leaders who will help guide our long-term strategy.

Get to know the board members

Why is this initiative valuable for us?

In today’s fast-changing world, staying competitive requires more than just operational excellence, it demands a visionary approach.

Our Board of Advisors brings:

Global industry expertise

Helping QbD Group scale and innovate with deep sector knowledge.

Independent insights

Challenging and refining our strategies with an objective perspective.

Extensive network

Facilitating collaborations and partnerships across the life sciences industry.

Proven leadership

Guiding companies through growth, transformation, and long-term success.

How the board supports QbD Group

The Board of Advisors has been formed to offer strategic counsel to QbD Group’s leadership, helping us navigate the evolving life sciences landscape.

By leveraging their expertise in international business growth, mergers & acquisitions, scientific advancements, and industry best practices, they provide an invaluable external perspective that strengthens our long-term strategy.

Our Board of Advisors helps by providing:

Strategic guidance rather than operational oversight.
An external perspective that complements our internal expertise.
Industry benchmarking and insights to refine our direction.

Willem van den Bruinhorst

Willem is a seasoned executive with over 35 years of experience in the healthcare industry. He has played a key role in the growth of leading companies like Medisize Group and Phillips-Medisize Corporation, specializing in Contract Design and Manufacturing Services (CDMO) for medical devices, drug delivery, and diagnostics. His expertise in private equity and global healthcare markets is invaluable to QbD Group.

I’m excited to bring my experience in scaling businesses to help QbD Group continue its impressive growth and make a lasting impact on the global healthcare sector.

Adam Sherlock

Adam has nearly 40 years of experience in the life sciences sector, leading professional services, technology, consultancy, and outsourcing companies. As CEO of multiple private equity-backed firms, he has driven remarkable growth and value creation. His deep understanding of the bio/pharma, IVD, and medical device industries positions him as a strategic asset to QbD Group.

I’m honored to be part of QbD Group’s exciting journey and look forward to helping them navigate new opportunities and challenges in the evolving life sciences market.

Mark Egerton

Mark brings more than 35 years of experience in pharmaceutical development and commercialization. As the former CEO of Quotient Sciences, he led an extraordinary phase of growth, significantly increasing revenue and shareholder value. His expertise in commercial strategy, operations, and scientific innovation makes him a valuable addition to QbD Group’s advisory team.

I’m excited to contribute to QbD Group’s continued success, helping them turn their innovative solutions into real value for the global life sciences community.